Spectrum T1423-25GM (SPFDB) Tamoxifen Citrate, USP, C26H29NO.C6H8O7, Reagent, Lab Grade

  • Manufacturing, quality management testing, and packaging are all carried out in spectrum’s very own amenities
  • This product is manufactured in united states
  • Expert use only

p h2t1423 54965-24-one Csub26/Subhsub29/subno Csub6/Subhsub8/Subosub7/sub/h2p tamoxifen citrate, USP is located in breast tissue as the antagonist of the estrogen receptor.It can also Act as an agonist and is the normal endocrine therapy for hormone receptor-optimistic breast cancer.The USP grade signifies it is graded suitable for personal care, cosmetic and pharmaceutical applications.All Spectrum chemical USP grade goods are produced, packaged and stored under recent good manufacturing practices (cGMP) per 21CFR portion 211 in FDA registered and inspected amenities.

This dissertation, “Regulation of Estrogen Receptor Alpha Expression by Translation or Degradation and the Relevance to Tamoxifen Resistance in Breast Cancer” by Chun, Gong, 龚纯, was obtained from The University of Hong Kong (Pokfulam, Hong Kong) and is being sold pursuant to Inventive Commons: Attribution 3. Hong Kong License. The articles of this dissertation has not been altered in any way. We have altered the formatting in order to facilitate the ease of printing and reading of the dissertation. All rights not granted by the above license are retained by the writer.
Abstract:
Breast cancer is a single of the most prevalent cancers affecting women throughout the world. In the breast, estrogen receptor alpha (ERα), upon binding with ligands, activates gene transcription and promotes cell development and proliferation. Tamoxifen, a selective antagonist of ERα in breast, has been proved to be effective therapeutically. In spite of this, resistance remains a prominent problem and underlying mec

Related: